ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Prolonged Survival with Co-Stimulatory Blockade Based Immunosuppression in Pig-to-Primate Liver Xenotransplantation.

J. Shah, M. Patel, N. Elias, I. Rosales, N. Navarro-Alvarez, M. Hertl, A. Cosimi, R. Colvin, J. Markmann, D. Sachs, P. Vagefi.

Massachusetts General Hospital, Boston, MA

Meeting: 2017 American Transplant Congress

Abstract number: 476

Keywords: Liver transplantation, Pig, Primates, Xenotransplantation

Session Information

Session Name: Concurrent Session: Xenotransplant

Session Type: Concurrent Session

Date: Tuesday, May 2, 2017

Session Time: 2:30pm-4:00pm

 Presentation Time: 2:54pm-3:06pm

Location: E351

Background:

Since the first attempt in 1968, survival following pig-to-baboon liver xenotransplantation (LXT) has been limited to <9-days due to a lethal coagulopathy. To improve survival, we developed a pre-clinical model utilizing human coagulation factor administration and co-stimulatory blockade.

Methods:

Four consecutive orthotopic pig-to-baboon LXT were performed using α1,3-galactosyltransferase knockout donors. Post-LXT, baboons received a continuous infusion of human prothrombin concentrate complex. Immunosuppression consisted of anti-thymocyte globulin, FK-506, methylprednisone and belatacept (n=3) or anti-CD40 mAb (n=1).

Results:

Belatacept Recipients: Baboon #1 survived until POD25 when euthanasia was performed due to worsening cholestasis and plantar ulcers. Baboon anti-pig cytotoxic IgM (but no IgG) was detected on POD7 with resolution by POD14 after steroid pulse. Final pathology was C4d negative and without evidence of rejection, inflammation, and TMA. Baboon #2 suffered a seizure requiring euthanasia on POD5 but at that time had normal LFT's and normal pathology. Baboon #3- the only recipient of CMV positive donor xenograft- necessitated euthanasia by POD8 due to worsening LFT's. Post-mortem liver pathology was C4d positive, with hemorrhagic necrosis and CMV inclusions. Circulating baboon anti-pig cytotoxic IgM (but no IgG) was detected on POD8. Anti-CD40 Recipient: Baboon #4 maintained stable hepatic function until euthanasia on POD29 due to plantar ulcers and rising LFT's. (Figure 1) No circulating antibody was detected, and final pathology was C4d negative and without evidence of rejection, inflammation, and TMA.

Conclusions:

We report nearly one-month survival in two recipients following pig-to-baboon LXT- the longest reported to date. The benefit of anti-CD40 mAb in preventing the development of baboon anti-pig cytotoxic IgM warrants further investigation. These results are encouraging for potential clinical application of LXT as a bridge to allotransplantation for patients with acute hepatic failure.

CITATION INFORMATION: Shah J, Patel M, Elias N, Rosales I, Navarro-Alvarez N, Hertl M, Cosimi A, Colvin R, Markmann J, Sachs D, Vagefi P. Prolonged Survival with Co-Stimulatory Blockade Based Immunosuppression in Pig-to-Primate Liver Xenotransplantation. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Shah J, Patel M, Elias N, Rosales I, Navarro-Alvarez N, Hertl M, Cosimi A, Colvin R, Markmann J, Sachs D, Vagefi P. Prolonged Survival with Co-Stimulatory Blockade Based Immunosuppression in Pig-to-Primate Liver Xenotransplantation. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/prolonged-survival-with-co-stimulatory-blockade-based-immunosuppression-in-pig-to-primate-liver-xenotransplantation/. Accessed June 6, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences